FPSA - FDA Issues Final Guidance for Industry on its Use of Remote Regulatory Assessments
Summary by FPSA
1 Articles
1 Articles
All
Left
Center
Right
FPSA - FDA Issues Final Guidance for Industry on its Use of Remote Regulatory Assessments
FDA recently published a final guidance for industry to describe and answer questions about FDA’s use of remote regulatory assessments (RRAs) to oversee and assure compliance of FDA-regulated products, outside of the COVID-19 pandemic. Read MoreThe post FDA Issues Final Guidance for Industry on its Use of Remote Regulatory Assessments appeared first on FPSA.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium